Obstetrics & Gynecology
Shannon Westin, MD
Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center; Director, Early Drug Development, Department of Gynecologic Oncology and Reproductive Medicine
Shannon N. Westin, MD, is a gynecologic oncologist at The University of Texas MD Anderson Cancer Center in Houston, TX, specializing in developmental therapeutics and biomarker-driven treatments for gynecologic malignancies. She focuses on advanced and recurrent ovarian cancer, endometrial cancer, uterine cancer, and other gynecologic cancers, developing rational combinatorial therapies with strong translational endpoints to inform bench research from clinical observations. As Director of Early
24+
Years in Practice
Credentials
Board Certifications
- Obstetrics & Gynecology
- Gynecologic Oncology
Education & Training
- University of Florida College of Medicine — M.D., 2002
- The University of Texas School of Public Health — MPH, Epidemiology, 2008
- University of Texas MD Anderson Cancer Center — Fellowship, Gynecologic Oncology, 2006-2010
- North Carolina Memorial Hospital-UNC — Residency, Obstetrics & Gynecology, 2003-2006
Peer Recognition
2022-2025 (4 years)
2023
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- The University of Texas MD Anderson Cancer Center
- Lyndon Baines Johnson Hospital
Languages
English
Experience
24+ years in practice